Results 41 to 50 of about 115,959 (294)

Multiple primary malignancies

open access: yesBangabandhu Sheikh Mujib Medical University Journal, 2017
Two cases of multiple primary malignancies (two or more neoplasms without any relationship between them) are presented in this paper. The first case (65 years) was a male in whom follicular carcinoma of thyroid, metachronous neuroendocrine tumor of ...
Dibanur Rashid Siddiqua   +3 more
doaj   +1 more source

Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management [PDF]

open access: yes, 2011
Bladder urothelial carcinoma is typically a disease of older individuals and rarely occurs below the age of 40 years. There is debate and uncertainty in the literature regarding the clinicopathologic characteristics of bladder urothelial neoplasms in ...
Paner, Gladell P   +9 more
core   +1 more source

The performance of the Xpert Bladder Cancer Monitor Test and voided urinary cytology in the follow-up of urinary bladder tumors [PDF]

open access: yes, 2021
Background: Cystoscopy in complement with urinary cytology represents the gold standard for the follow-up of patients with urinary bladder tumours. Xpert Bladder Cancer Monitor Test (XBC) is a novel mRNA-based urine test for bladder cancer surveillance ...
Fabjan, Teja   +9 more
core   +2 more sources

Secondary Neoplasms of the Urinary Bladder-Clinical Management and Oncological Outcomes [PDF]

open access: yes, 2021
Background: Secondary neoplasms of the bladder account for 4.5% of all bladder neoplasms however there is limited literature reporting management and survival.
El-Taji, Omar   +7 more
core   +1 more source

A rare case of seminoma metastasis to the bladder

open access: yesВестник урологии
Introduction. The great majority of testis neoplasms are germ cell tumours. The most common site of metastasis is the retroperitoneal region. Metastasis to the bladder is very rare.Clinical case.
Muhamad Al-Tawil
doaj   +1 more source

Evaluation of bladder washings cytology in diagnosis of neoplasms of urinary bladder

open access: yesIP Archives of Cytology and Histopathology Research, 2022
Urinary cytology functions as the primary screening and surveillance modality for the detection of urothelial neoplasia. To determine the significance of urinary bladder wash cytology in predicting various grades of urothelial carcinoma of urinary bladder along with their histological confirmation.
Niti Dalal   +5 more
openaire   +2 more sources

Liquid biopsy‐based diagnostic evaluation of hypermethylated CpG sites for ovarian cancer diagnosis

open access: yesMolecular Oncology, EarlyView.
This schematic outlines the workflow from biomarker identification to duplex MethyLight assay validation for epithelial ovarian cancer diagnosis using cfDNA‐based liquid biopsy. Initial screening of hypermethylated CpG candidates (cg02957270, cg10061138 cg00480298, COL2A1) was performed in tissue using ARMS‐PCR, COBRA, qPCR and image analysis. Selected
Deepa Bisht   +3 more
wiley   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola   +11 more
wiley   +1 more source

Solitary fibrous tumor of urinary bladder in a female patient and transurethral enucleation of tumor

open access: yesActa Medica Alanya, 2018
Solitary fibrous tumors are rare neoplasms, initially defined in visceral pleura. Recently, they have been noticed to have ubiquitous distribution of human body. Solitary fibrous tumor of bladder is extremely rare especially in the females.
Ali Akkoç   +2 more
doaj   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

open access: yesMolecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy